CN103083541A - 一种治疗贫血的药物 - Google Patents
一种治疗贫血的药物 Download PDFInfo
- Publication number
- CN103083541A CN103083541A CN2013100581325A CN201310058132A CN103083541A CN 103083541 A CN103083541 A CN 103083541A CN 2013100581325 A CN2013100581325 A CN 2013100581325A CN 201310058132 A CN201310058132 A CN 201310058132A CN 103083541 A CN103083541 A CN 103083541A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- anemia
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 208000007502 anemia Diseases 0.000 title claims abstract description 40
- 229940079593 drug Drugs 0.000 title abstract description 7
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 14
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 14
- 108010052008 colla corii asini Proteins 0.000 claims abstract description 14
- 241000545442 Radix Species 0.000 claims description 18
- 241000756943 Codonopsis Species 0.000 claims description 13
- 241000208340 Araliaceae Species 0.000 claims description 12
- 241000221377 Auricularia Species 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 210000002826 placenta Anatomy 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 241000245240 Lonicera Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 abstract description 39
- 239000008280 blood Substances 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 20
- 208000002173 dizziness Diseases 0.000 abstract description 5
- 210000002216 heart Anatomy 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 4
- 206010033557 Palpitations Diseases 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 208000000059 Dyspnea Diseases 0.000 abstract description 2
- 206010013975 Dyspnoeas Diseases 0.000 abstract description 2
- 208000013220 shortness of breath Diseases 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000007126 Codonopsis pilosula Species 0.000 abstract 2
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 208000013433 lightheadedness Diseases 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 25
- 210000004185 liver Anatomy 0.000 description 21
- 102000001554 Hemoglobins Human genes 0.000 description 18
- 108010054147 Hemoglobins Proteins 0.000 description 18
- 241000700159 Rattus Species 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 16
- 229910052742 iron Inorganic materials 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 206010022971 Iron Deficiencies Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 235000021242 lactoferrin Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310058132.5A CN103083541B (zh) | 2013-02-02 | 2013-02-02 | 一种治疗贫血的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310058132.5A CN103083541B (zh) | 2013-02-02 | 2013-02-02 | 一种治疗贫血的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103083541A true CN103083541A (zh) | 2013-05-08 |
CN103083541B CN103083541B (zh) | 2015-01-28 |
Family
ID=48197020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310058132.5A Expired - Fee Related CN103083541B (zh) | 2013-02-02 | 2013-02-02 | 一种治疗贫血的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103083541B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103405603A (zh) * | 2013-08-26 | 2013-11-27 | 费海荣 | 一种治疗贫血的复合药物组合物 |
CN103566167A (zh) * | 2013-09-29 | 2014-02-12 | 山东东阿阿胶股份有限公司 | 一种含阿胶的不上火的中药组合物及其制备方法 |
CN103933203A (zh) * | 2014-04-01 | 2014-07-23 | 陕西医大血友病研究院 | 一种用于治疗再生障碍性贫血的复方生血胶囊及其制备方法 |
CN104208267A (zh) * | 2014-09-26 | 2014-12-17 | 张永胜 | 一种用于治疗产后贫血的中药或者保健品 |
CN104398794A (zh) * | 2014-10-30 | 2015-03-11 | 张坤镛 | 一种修护红细胞的中药制剂 |
CN104644847A (zh) * | 2014-06-16 | 2015-05-27 | 刘波 | 治疗贫血的中药组合物 |
CN104758781A (zh) * | 2015-03-18 | 2015-07-08 | 兰晓光 | 一种治疗脾气虚弱型缺铁性贫血的中药组合物 |
CN104770734A (zh) * | 2015-04-30 | 2015-07-15 | 杭州索契科技有限公司 | 一种具有改善贫血作用的阿胶组合物 |
CN104940587A (zh) * | 2015-06-04 | 2015-09-30 | 刘和花 | 一种治疗贫血的中药组合物 |
CN105194522A (zh) * | 2015-11-10 | 2015-12-30 | 李玉宾 | 一种治疗贫血的中药组合物及其制备方法 |
CN105267935A (zh) * | 2015-11-25 | 2016-01-27 | 范征美 | 一种治疗小儿缺铁性贫血的中药制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101278987A (zh) * | 2008-05-04 | 2008-10-08 | 北京中科仁和科技有限公司 | 一种滋阴补肾、益气活血、补血填精的中药组合 |
CN101536779A (zh) * | 2009-04-24 | 2009-09-23 | 山东华信制药集团股份有限公司 | 一种胶剂系列产品 |
CN102872363A (zh) * | 2012-10-25 | 2013-01-16 | 吴伶 | 一种治疗贫血的中药口服液 |
-
2013
- 2013-02-02 CN CN201310058132.5A patent/CN103083541B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101278987A (zh) * | 2008-05-04 | 2008-10-08 | 北京中科仁和科技有限公司 | 一种滋阴补肾、益气活血、补血填精的中药组合 |
CN101536779A (zh) * | 2009-04-24 | 2009-09-23 | 山东华信制药集团股份有限公司 | 一种胶剂系列产品 |
CN102872363A (zh) * | 2012-10-25 | 2013-01-16 | 吴伶 | 一种治疗贫血的中药口服液 |
Non-Patent Citations (3)
Title |
---|
《当你患贫血时-最贴近患者的心声》 20050131 戴光熙等 "中药治疗贫血有哪些组方" 山西科学技术出版社 第186-187页 1-4 , 第1版 * |
张冰等: "《中药治疗学》", 31 May 2008, article ""贫血"", pages: 150-153 * |
戴光熙等: "《当你患贫血时—最贴近患者的心声》", 31 January 2005, article ""中药治疗贫血有哪些组方"", pages: 186-187 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103405603A (zh) * | 2013-08-26 | 2013-11-27 | 费海荣 | 一种治疗贫血的复合药物组合物 |
CN103566167A (zh) * | 2013-09-29 | 2014-02-12 | 山东东阿阿胶股份有限公司 | 一种含阿胶的不上火的中药组合物及其制备方法 |
CN103566167B (zh) * | 2013-09-29 | 2016-04-13 | 山东东阿阿胶股份有限公司 | 一种含阿胶的不上火的中药组合物及其制备方法 |
CN103933203B (zh) * | 2014-04-01 | 2015-10-28 | 陕西医大血友病研究院 | 一种用于治疗再生障碍性贫血的复方生血胶囊及其制备方法 |
CN103933203A (zh) * | 2014-04-01 | 2014-07-23 | 陕西医大血友病研究院 | 一种用于治疗再生障碍性贫血的复方生血胶囊及其制备方法 |
CN104644847A (zh) * | 2014-06-16 | 2015-05-27 | 刘波 | 治疗贫血的中药组合物 |
CN104208267A (zh) * | 2014-09-26 | 2014-12-17 | 张永胜 | 一种用于治疗产后贫血的中药或者保健品 |
CN104208267B (zh) * | 2014-09-26 | 2016-03-23 | 张永胜 | 一种用于治疗产后贫血的中药或者保健品 |
CN104398794A (zh) * | 2014-10-30 | 2015-03-11 | 张坤镛 | 一种修护红细胞的中药制剂 |
CN104758781A (zh) * | 2015-03-18 | 2015-07-08 | 兰晓光 | 一种治疗脾气虚弱型缺铁性贫血的中药组合物 |
CN104770734A (zh) * | 2015-04-30 | 2015-07-15 | 杭州索契科技有限公司 | 一种具有改善贫血作用的阿胶组合物 |
CN104940587A (zh) * | 2015-06-04 | 2015-09-30 | 刘和花 | 一种治疗贫血的中药组合物 |
CN105194522A (zh) * | 2015-11-10 | 2015-12-30 | 李玉宾 | 一种治疗贫血的中药组合物及其制备方法 |
CN105267935A (zh) * | 2015-11-25 | 2016-01-27 | 范征美 | 一种治疗小儿缺铁性贫血的中药制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN103083541B (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103083541B (zh) | 一种治疗贫血的药物 | |
CN100415268C (zh) | 治疗气管炎、肺气肿咳喘的药酒 | |
CN100368006C (zh) | 一种治疗心血管疾病的药物 | |
CN103041209B (zh) | 一种治疗肾阴虚的中药制剂及其制备方法 | |
CN103550532B (zh) | 一种治疗心悸的中药组合物 | |
CN101879291A (zh) | 解郁安神合剂汤(加散)、丸 | |
CN105727145A (zh) | 用于治疗脾虚痰湿证型高脂血症的中药药物 | |
CN105311219A (zh) | 强身解郁宁神合剂 | |
CN103356944A (zh) | 一种治疗贫血的中药组合物 | |
CN103301211B (zh) | 一种治疗白细胞减少症的中药 | |
CN101711809A (zh) | 一种治疗产后抑郁症的药物组合物及制备方法和用途 | |
CN104491733A (zh) | 一种中药制剂用于制备治疗贫血、气虚乏力药物中的用途 | |
CN104306891A (zh) | 一种治疗神经衰弱的中药 | |
CN103285173B (zh) | 一种治疗血小板减少性紫癜的中药 | |
CN105434738A (zh) | 一种治疗小儿多动症的中药组合物及其制备方法 | |
CN100560117C (zh) | 一种健脾胃、养肝肾的中药组合物及其制备方法 | |
CN105796845A (zh) | 药物组合物在制备治疗女性更年期综合征药物中的用途 | |
CN105194301A (zh) | 一种治疗慢性心力衰竭的中药制剂 | |
CN105343675A (zh) | 一种治疗肥胖症的中药制剂及其制备方法 | |
CN104352717A (zh) | 一种治疗脾气虚弱型便血的中药制剂及其制备方法 | |
CN103316106A (zh) | 丹山消脂颗粒及其制备方法 | |
CN103751415B (zh) | 一种中药组合物及其制备方法 | |
CN104435478B (zh) | 用于治疗睡眠障碍的中药组合物、制备方法及用途 | |
CN102973817A (zh) | 一种治疗动脉粥样硬化的中药复方制剂及其制备方法 | |
CN105941773A (zh) | 一种保健茶及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI MIN Free format text: FORMER OWNER: XU MEILING Effective date: 20141222 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Min Inventor after: Liu Junrong Inventor before: Xu Meiling Inventor before: Meng Xianlan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262600 WEIFANG, SHANDONG PROVINCE TO: 262500 WEIFANG, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: XU MEILING MENG XIANLAN TO: LI MIN LIU JUNRONG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141222 Address after: 262500, Shandong City, Qingzhou Huang Lou Subdistrict Office, Lu Star Street, No. 887, Qingzhou Huang Lou Health Hospital Branch Applicant after: Li Min Address before: The 262600 Shandong city of Weifang province Linqu County Road No. 21 Applicant before: Xu Meiling |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150128 Termination date: 20160202 |
|
CF01 | Termination of patent right due to non-payment of annual fee |